Condition (MeSH)
Endometritis
ClinicalTrials.gov lists 38 trials for Endometritis or a narrower condition beneath it. Western Galilee Hospital-Nahariya has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
38 of the 38 trials are tagged with Endometritis itself; the rest are tagged with a narrower condition beneath it.
When did Endometritis trials start? (18)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2023 | 1 |
| 2021 | 2 |
| 2020 | 2 |
| 2019 | 4 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 3 |
| 2014 | 2 |
Showing 10 of 18 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Endometritis trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 2/3 | 1 |
| Phase 4 | 5 |
| Not applicable | 22 |
| Observational | 5 |
How many Endometritis trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Completed | 17 |
| Terminated | 5 |
| Withdrawn | 3 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Endometritis trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Western Galilee Hospital-Nahariya | 2 |
| Clinique Ovo | 1 |
| Faculty Hospital Kralovske Vinohrady | 1 |
| Federal Teaching Hospital Abakaliki | 1 |
| Hillel Yaffe Medical Center | 1 |
Which drugs are being tested for Endometritis? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Cefoxitin | 2 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 1% Azithromycin | 2 |
| CEZ, cefazolin sodium | 2 |
| Iodine povidone | 2 |
| IM Oxytocin | 1 |
| Ampicillin + gentamicin | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Endometritis trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Severe allergic reaction | 44 | 1 |
Which publications cover Endometritis? (139)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| FuKe QianJin capsule alleviates endometritis via inhibiting inflammation and pyroptosis through modulating TLR4/ NF-κB /NLRP3 pathway. | Journal of ethnopharmacology | 2025 | Yes |
| Pelvic peritoneal endometriosis is linked to the endometrial inflammatory profile: a prospective cohort study. | BMC women's health | 2025 | Yes |
| The pathogenesis, diagnosis, and treatment of chronic endometritis: a comprehensive review. | Frontiers in endocrinology | 2025 | Yes |
| Administration of levofloxacin combined with metronidazole suppositories prior to in vitro fertilisation in women with chronic endometritis: a protocol of a single-centre, randomised, controlled clinical trial. | BMJ open | 2025 | Yes |
| Chronic endometritis diagnosis and fertility outcomes: an old unresolved question. | Reproduction & fertility | 2025 | Yes |
Showing 5 of 139 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.